ATLANTA — In this Healio video exclusive, Seth S. Martin, MD, MHS, FAHA, discusses research into lipid disorders from the American College of Cardiology Scientific Session, examining a study on lipid ...

Please provide your email address to receive an email when new articles are posted on . The FDA extended its approval of alirocumab to treat a genetic lipid disorder in patients as young as 8 years.

This statement summarizes the current U.S. Preventive Services Task Force (USPSTF) recommendation on screening for lipid disorders in children. This recommendation statement was first published in ...

Familial Hypobetalipoproteinemia (FHBL), caused by variants in the apolipoprotein B (APOB) gene, is a rare autosomal co-dominant monogenic disorder characterized by lifelong low plasma levels of total ...

Seville, Spain - In an attempt to address one of the major stumbling blocks in identifying a genetic or metabolic marker for familial combined hyperlipidemia (FCH), researchers from the Netherlands ...

Researchers have developed a new compound, ZTA-261, that binds to thyroid hormone receptor beta (THR ). THR plays an important role in the regulation of lipid metabolism, which affects lipid levels in ...

Metabolic dysregulation has been implicated in major depressive disorder (MDD), but the causal relationship between plasma ...

When eating, the body converts extra calories, especially from carbs, sugar, fats, and alcohol, into triglycerides.

The practice of lipid screening in children still hasn't taken off despite guideline recommendations to do so as early as age 9 years, according to a large cross-sectional study. U.S. records show ...

For the best experience, please enable JavaScript in your browser settings. A team of medics performing CPR and inserting an IV drip on a patient lying unconscious in ...

Chanarin-Dorfman syndrome (CDS) is a rare autosomal recessive disorder manifesting predominantly as congenital ichthyosiform erythroderma and systemic accumulation of neutral lipids. Mutations in the ...